Results 161 to 170 of about 5,752 (241)

Diabetic Peripheral Neuropathy: Molecular Staging, Risk Factors, Therapeutics, and Emerging Trends

Med Research, Volume 2, Issue 2, Page 309-342, June 2026.
The heterogeneous landscape of DPN can be unified through a tripartite pathogenic model encompassing progressive stages of metabolic dysregulation, chronic inflammation, and overt neuronal damage. Within this framework, six clinical subtypes were identified, namely, hyperglycemia‐driven, dyslipidemia‐driven, inflammation‐driven, dysvascularity‐driven ...
Xiaofeng Dai, Mingze Tang
wiley   +1 more source

Differentiation of Horner Syndrome and Physiological Anisocoria by Automated Pupillometry. [PDF]

J Neuroophthalmol
Disse LR, Bockisch CJ, Weber KP, Fierz FC.   +3 more
europepmc   +1 more source

Starch-iodine test: a diagnostic tool for Horner syndrome. [PDF]

BMJ Case Rep, 2020
Ribeiro L, Rocha R, Martins J, Monteiro A.   +3 more
europepmc   +1 more source

X‐Linked Intellectual Developmental Disorder‐93 Caused by BRWD3 Mutation in Females: A Case Report and Literature Review

Molecular Genetics &Genomic Medicine, Volume 14, Issue 6, June 2026.
A case of MRX93 in a 1‐year‐and‐3‐month‐old girl was reported, in whom a heterozygous deletion from exon 21 to exon 30 in the BRWD3 gene occurred. We conducted a literature review to explore the clinical phenotypes and genetic characteristics of MRX93 in females. ABSTRACT Objective To report the clinical manifestations and genetic diagnosis of a female
Yang Xiu, Yige Zhang, Yake Jiao, Wei Wang, Yanyan Hu   +4 more
wiley   +1 more source

Horner Syndrome Following Permcath Insertion in a Child with End-Stage Renal Disease: A Case Report. [PDF]

Iran J Child Neurol
Mohkam M, Fatollahierad S, Ahmadabadi F, Khalili M.   +3 more
europepmc   +1 more source

What Role Does the Central Nervous System Play in Refractory LUTS, and What Are the Therapeutic Implications? ICI‐RS 2025

Neurourology and Urodynamics, Volume 45, Issue 5, Page 929-936, June 2026.
ABSTRACT Aims While many patients with lower urinary tract symptoms (LUTS) improve by treating peripheral causes, a substantial proportion continue to experience symptoms despite apparently successful interventions. Central nervous system (CNS) mechanisms could potentially contribute to persisting symptoms after the initial peripheral cause has been ...
Mathijs M. de Rijk, Michel Wyndaele, Ana Charrua, Christopher Fry, Paul Abrams, Gommert A. van Koeveringe, Anthony J. Kanai, Marcus J. Drake   +7 more
wiley   +1 more source

Graph‐Theoretical Approach for Predicting Physicochemical Properties of Stiff‐Person Syndrome Drugs

ChemistryOpen, Volume 15, Issue 6, June 2026.
Graph‐theoretical descriptors derived from M‐polynomials are integrated with quantitative structure–property relationship modeling and machine learning to uncover structure–property relationships of drugs used in stiff‐person syndrome. Strong correlations between degree‐based topological indices and key physicochemical properties are revealed ...
Jabbar Ali, Yasir Ali, Maher Ali Malik, Yilun Shang   +3 more
wiley   +1 more source

The importance of longitudinal evaluation using DAT‐SPECT in organophosphate‐induced toxic parkinsonism

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
We performed longitudinal evaluation using magnetic resonance imaging (MRI) and dopamine transporter single‐photon emission computed tomography (DAT‐SPECT) in a case of organophosphate‐induced toxic parkinsonism. Fluid‐attenuated inversion recovery (FLAIR) images showed bilateral striatal hyperintensity in the acute phase, followed by reduction of ...
Shuhei Nakao, Yoichiro Kogoh, Hideki Funahashi, Yusei Yanoma, Minako Azuma, Yasushi Ishida, Yoji Hirano   +6 more
wiley   +1 more source

A Rare Presentation of Guillain-Barré Syndrome With Associated Horner Syndrome: A Case Report. [PDF]

Cureus
Irfan S, Ganesan J, Jain KV, A P GA, Ravichandran U.   +4 more
europepmc   +1 more source